Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm

Clinical trial NCT01825824 · UNKNOWN

Trial details

NCT number: NCT01825824
Sponsor: Korea Cancer Center Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2012-06-01
Primary completion: 2015-06-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.